MedPath

Investigating the Safety of Edaravone in Aluminum Phosphide Poisoning.

Phase 1
Recruiting
Conditions
Aluminum phosphide poisoning.
Toxic effect of phosphorus and its compounds
T57.1
Registration Number
IRCT20090627002083N8
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Aluminum phosphide poisoning

Exclusion Criteria

Negative silver nitrate test
Age less than 18 and more than 60 years
Concomitant poisoning with drugs or other compounds
Heart failure disease
Patients with asthma

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath